**Introduction:** The management of psoriatic arthritis differs significantly from that of gout but there is known to be an association between the two pathologies. This report highlights a case which presented our team with notable challenges in both diagnosis and management of the underlying cause of the patient\'s symptoms.

**Case description:** A 54 year old female was referred to clinic with a six month history of joint pain, stiffness and swelling, affecting her hands and feet. She reported the pain as being severe, affecting her ability to type and walk, with morning stiffness lasting for more than two hours. On examination, she had marked synovitis of her right second MCP joint and the interphalangeal joints of her feet. Psoriatic plaques were also noted on her scalp, wrists and knees with no evidence of nail changes. Systemic examination was otherwise normal. Her past medical history included hypertension, hiatus hernia, asthma and depression with a family history of psoriasis. Her rheumatoid factor had been checked previously and was found to be elevated at over 800 IU/ml with an ESR of 52 mm/hr. She had a high alcohol intake of more than 35 units a week. In view of this and the severity of the pain, our differential diagnosis included gout in addition to psoriatic and rheumatoid arthritis. She was given an intramuscular steroid injection and advised to return for review one week later following further investigation. Plain radiographs of her feet were normal, together with her ANA, anti-dsDNA and ANCA levels. Her serum uric acid levels were however raised at 461 µmol/L (normal range 110-360) and she was noted to have an erosion at the base of the proximal phalanx of her right index finger on radiographs of her hands. The nature of the erosion was highly suggestive of a tophaceous erosion and a diagnosis of gout was made. There had been no improvement in her symptoms following the intramuscular steroid injection at her initial clinic visit and she continued to have florid synovitis on returning for review. She was started on prednisolone 20mg with a view to commencing uricosuric treatments for gout once the synovitis was better controlled. There was a significant improvement in her symptoms with oral steroids. After two weeks, she was started on allopurinol and weaned off prednisolone. Colchicine was added in once daily for prophylaxis after a further two weeks. Over the festive season, the patient disclosed that she drank significant amounts of alcohol on a daily basis. She reported having multiple attacks of joint pain and swelling over the past month, particularly affecting her left foot. She was advised to reduce her alcohol intake and continue with regular allopurinol and colchicine. Despite successfully managing to reduce her alcohol intake and her serum uric acid returning to normal levels, she continued to have widespread synovitis. Her psoriasis was also noted to have flared and after joint clinic review with dermatology, she was started on methotrexate for a presumed diagnosis of psoriatic arthritis. She continues to have debilitating flares of synovitis despite being on methotrexate for four months. There is very limited improvement in pain with the use of etorcoxib and topical ibuprofen gel. As a consequence, she has difficulty walking and is no longer able to work. She reported a patient global assessment disease activity score of 10 at her most recent clinic visit. Her methotrexate dose has now been escalated to 20mg with a view to reviewing her symptoms in two months.

**Description:** The case demonstrates a diagnostic dilemma, which has had a significant impact on the effective management of this patient's symptoms. On her initial clinic visit, multiple differentials were considered including both psoriatic arthritis and gout. The results from her biochemical and radiological investigations, as well as her history of high alcohol intake, led us to believe gout was the primary cause of her arthritis. The possibility of her having both gout as well as psoriatic arthritis was not considered until much later and we now believe that the psoriatic arthritis is the principal cause of this patient's ongoing problems. Several studies and reports in the literature have documented the association of psoriasis and psoriatic arthritis with hyperuricaemia. We would be grateful for the opinion of our colleagues as to whether they would have managed the case any differently given her initial presentation. If her symptoms remain poorly controlled on the increased dose of methotrexate, it would be useful to know if our colleagues would choose combination DMARD therapy or a biologic agent as the next line of treatment.

**Key learning points:** It is important to remember that multiple pathologies can coexist and that there is not always a single unifying diagnosis. We would like to learn what the optimum management of this case of both active gout and psoriatic arthritis would be from the conference.
